Please login to the form below

Not currently logged in
Email:
Password:

Actelion appoints former GSK CEO as chair

Dr Jean-Pierre Garnier, former CEO at GlaxoSmithKline, has been appointed chairman of Swiss biopharmaceutical company Actelion

Dr Jean-Pierre Garnier - ActelionDr Jean-Pierre Garnier, former CEO at GlaxoSmithKline (GSK), has been appointed chairman of Swiss biopharmaceutical company Actelion.

He will take over from Robert Cawthorn who will remain in the role until the company's annual general meeting in 2012.

Garnier was first appointed to Actelion's board of directors at the company's annual general meeting on May 5, 2011.

His previous positions include the CEO of GSK following the merger of SmithKline Beecham and Glaxo Wellcome in 2001. He remained at GSK until 2008 when he became CEO of French pharmaceutical and cosmetics company Pierre Fabre Labs.

Prior positions at SmithKline Beecham include president of the company's pharmaceutical business in North America, as well as chairman of its pharmaceuticals division and chief operating officer.

Jean-Paul Clozel, co-founder and CEO of Actelion, described Garnier as "one of the world's most renowned pharma managers" following the announcement.

He said: "He is the right person to lead Actelion into the next stage of the company's development."

28th September 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics